Endo Tools raises $3.3M; Direct Flow launches TAVI trial;

@FierceMedDev: Intuitive's surgical robots slammed in another study. Story | Follow @FierceMedDev

@DamianFierce: Another FDA roadblock for Guided Therapeutics and its cervical scanner. Article | Follow @DamianFierce

@MarkHFierce: NanoString is ramping up the U.S. commercial launch for its breast cancer prognostic Dx. Item | Follow @MarkHFierce

@MichaelGFierce: CeQur closes $27M round to fund insulin delivery device. More from FierceDrugDelivery | Follow @MichaelGFierce

> Endo Tools Therapeutics, a Belgian maker of obesity-treating devices, has hauled in $3.3 million to develop its technology. More

> First time premarket approvals for med tech companies are down 47% since 2012, and M&A activity is also on the decline for the broader industry, EvaluateMedTech concludes in a new report. Item

> Louisiana's Moirai Orthopaedics gained a CE mark for its new pyrocarbon implant knee replacement system, and the initial launch will take place in Australia and England. Item

> Germany's Activaero has forged a research collaboration deal with Italy's Chiesi Farmaceutici to jointly evaluate a drug/device combination product using Activaero's inhalation technology to develop a cystic fibrosis treatment. Item

> Breast imaging outfit Delphinus Medical has locked down a $6 million term loan from GE Capital to get its SoftVue tomography system to market. News

> InspireMD, a maker of embolic protection stents, has cut back on its Israeli manufacturing and hired a European distribution company. Story

> California's Direct Flow Medical has enrolled the first patient in its U.S. SALUS clinical trial, which will study the company's transcatheter aortic heart valve system. Item

Biotech News

@FierceBiotech: Merck R&D chief spotlights streamlining, biologics and the new risk strategy. Article | Follow @FierceBiotech

@JohnCFierce: You can add real estate to AstraZeneca's (long) list of bad investments. Story | Follow @JohnCFierce

@Ry_McBride: Busy Biogen Idec fuels Amicus in Parkinson's drug chase. More | Follow @Ry_McBride

> Remicade knockoff delivers pioneering antibody biosimilar OK for Hospira, Celltrion. Story

> Roche's cancer immunotherapy quest spurs $422.5M Inovio combo deal. Article

> Neurocrine shares damaged by low-dose drug pratfall in PhIIb. Story

> Cold Spring Harbor Lab names Teri Willey as new BD chief. Item

Pharma News

@FiercePharma: Italy's Recordati set to buy Spain's Laboratorios Casen Fleet for $122.4M. More | Follow @FiercePharma

@EricPFierce: J&J recalls infant Motrin after API found to have tiny plastic bubbles. Story | Follow @EricPFierce

@CarlyHFierce: New FDA guidance on generics for combo inhaled drugs is bad news for GSK/Advair. Article | Follow @CarlyHFierce

> Forest Labs taps ex-Bausch + Lomb chief to replace Solomon as CEO. More

> New FDA guidance threatens GlaxoSmithKline's Advair. Article

Biotech Research News

@EmilyMFierce: Drug combo could treat deadly coronavirus. More | Follow @EmilyMFierce

> Immune cell discovery could help fight diabetes, arthritis, MS. Story

> Amicus, Biogen Idec form Parkinson's drug development pact. News

> Potential Parkinson's-fighting compounds identified. Article

> Compound restores learning deficits in Down syndrome mice. More

> Advaxis treatment stops HPV tumor growth, extends survival in animals. Item

Pharma Manufacturing News

> India's economic meltdown pushes Biocon to build elsewhere. Story

> Piramal investing $11M in U.K. plant. News

> Burglar admits heists at Lilly, Glaxo warehouses. Report

> Altaire recalls moldy eye solution made for Walmart, CVS, Target. More

> Banner manufacturing powers Patheon growth. Article

> J&J's troubled McNeil unit recalls more products. Report

Suggested Articles

U.K.-based surgery robot developer CMR Surgical has begun rolling out its Versius platform to the NHS, completing its first procedures in Europe.

The former Fierce 15 winner’s SuperMap program was cleared to guide electrophysiologists in the treatment of stable and transient arrhythmias.

Insulet announced new agreements with Abbott and Dexcom to connect their continuous glucose monitors with its upcoming tubeless, digital insulin pump,